A California-based biotech found some serious success on Wednesday after the company received FDA fast track designation for Troculeucel, used for the treatment of moderate...

To read the full story on AllPennyStocks.com, click here.

NKGen Biotech (NASDAQ:NKGN)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more NKGen Biotech Charts.
NKGen Biotech (NASDAQ:NKGN)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more NKGen Biotech Charts.